Mizuho Securities USA LLC Sells 1,066 Shares of Axon Enterprise, Inc (NASDAQ:AXON)

Key Points

• Mizuho Securities USA LLC reduced its stake in Axon Enterprise by 15.5%, now holding 5,800 shares, valued at approximately $3,051,000.
• Significant investment activity was noted, with Capital World Investors increasing its stake by 86.4% and GAMMA Investing LLC expanding its holdings by 58,725.5% in the first quarter.
• Axon Enterprise's recent earnings report showed a 32.6% increase in revenue year-over-year, with earnings per share of $2.12, exceeding analysts' expectations.

Mizuho Securities USA LLC cut its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 15.5% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,800 shares of the biotechnology company's stock after selling 1,066 shares during the period. Mizuho Securities USA LLC's holdings in Axon Enterprise were worth $3,051,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Capital World Investors raised its stake in shares of Axon Enterprise by 86.4% during the 4th quarter. Capital World Investors now owns 1,815,765 shares of the biotechnology company's stock worth $1,079,145,000 after purchasing an additional 841,772 shares during the period. GAMMA Investing LLC increased its holdings in Axon Enterprise by 58,725.5% in the 1st quarter. GAMMA Investing LLC now owns 764,731 shares of the biotechnology company's stock worth $402,210,000 after acquiring an additional 763,431 shares during the last quarter. Jennison Associates LLC increased its holdings in Axon Enterprise by 23,203.7% in the 1st quarter. Jennison Associates LLC now owns 614,053 shares of the biotechnology company's stock worth $322,961,000 after acquiring an additional 611,418 shares during the last quarter. Westfield Capital Management Co. LP increased its holdings in Axon Enterprise by 29.8% in the 1st quarter. Westfield Capital Management Co. LP now owns 927,801 shares of the biotechnology company's stock worth $487,977,000 after acquiring an additional 212,931 shares during the last quarter. Finally, Vanguard Group Inc. increased its holdings in Axon Enterprise by 2.2% in the 1st quarter. Vanguard Group Inc. now owns 8,632,008 shares of the biotechnology company's stock worth $4,540,005,000 after acquiring an additional 185,571 shares during the last quarter. 79.08% of the stock is currently owned by institutional investors.

Axon Enterprise Stock Performance

Shares of AXON opened at $842.50 on Monday. The company has a market cap of $66.14 billion, a PE ratio of 208.02, a price-to-earnings-growth ratio of 30.92 and a beta of 1.36. The company has a current ratio of 2.95, a quick ratio of 2.71 and a debt-to-equity ratio of 0.63. The stock has a 50-day moving average price of $774.27 and a 200-day moving average price of $665.44. Axon Enterprise, Inc has a 12-month low of $346.71 and a 12-month high of $885.91.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, topping analysts' consensus estimates of $1.54 by $0.58. The company had revenue of $668.54 million during the quarter, compared to the consensus estimate of $641.77 million. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%. Axon Enterprise's quarterly revenue was up 32.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.20 EPS. As a group, equities analysts forecast that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, Director Michael Garnreiter sold 5,913 shares of the business's stock in a transaction that occurred on Wednesday, June 4th. The stock was sold at an average price of $760.00, for a total value of $4,493,880.00. Following the completion of the sale, the director owned 17,740 shares in the company, valued at $13,482,400. The trade was a 25.00% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 1,300 shares of the business's stock in a transaction that occurred on Monday, May 19th. The stock was sold at an average price of $738.84, for a total value of $960,492.00. Following the completion of the sale, the director owned 4,829 shares of the company's stock, valued at $3,567,858.36. The trade was a 21.21% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 24,985 shares of company stock worth $18,480,838 over the last ninety days. Corporate insiders own 5.70% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on AXON shares. Craig Hallum raised Axon Enterprise from a "hold" rating to a "buy" rating and set a $900.00 price objective for the company in a report on Tuesday, August 5th. Wolfe Research started coverage on Axon Enterprise in a report on Monday, July 7th. They set an "outperform" rating for the company. JPMorgan Chase & Co. lifted their target price on Axon Enterprise from $730.00 to $850.00 and gave the company an "overweight" rating in a report on Thursday, July 17th. Barclays lifted their target price on Axon Enterprise from $726.00 to $735.00 and gave the company an "overweight" rating in a report on Friday, May 9th. Finally, UBS Group reaffirmed a "neutral" rating and set a $840.00 target price (up previously from $820.00) on shares of Axon Enterprise in a report on Tuesday, August 5th. Two equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $837.69.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.